| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S2213-8587(18)30021-4 |
| P698 | PubMed publication ID | 29396245 |
| P50 | author | Catey Bunce | Q28039205 |
| Peter N. Taylor | Q38548880 | ||
| Richard W J Lee | Q57020350 | ||
| P2093 | author name string | Daniel G Ezra | |
| Robert Hills | |||
| Helen M Herbert | |||
| Andrew D Dick | |||
| Nicola Harris | |||
| Rajni Jain | |||
| Geoffrey E Rose | |||
| Jimmy M Uddin | |||
| Carol Lane | |||
| Colin M Dayan | |||
| Nichola Rumsey | |||
| Daniel Morris | |||
| Nicholas Plowman | |||
| Nachi Palaniappan | |||
| Sue Jackson | |||
| Suzannah R Drummond | |||
| Ewan Kemp | |||
| Steven J Hurel | |||
| Julie Pell | |||
| Jane Olver | |||
| Fion Bremner | |||
| Olivia C Morris | |||
| Victoria J Wilson | |||
| Mike J Potts | |||
| Rathie Rajendram | |||
| Helen Garrott | |||
| Anne Cook | |||
| Diana M Ritchie | |||
| Marjorie Tomlinson | |||
| Rao Gattamaneni | |||
| Chunhei Li | |||
| Sue Yarrow | |||
| P2860 | cites work | A randomised double-blind trial of cyclosporin and azathioprine in refractory rheumatoid arthritis | Q28325989 |
| Protocol for the combined immunosuppression & radiotherapy in thyroid eye disease (CIRTED) trial: a multi-centre, double-masked, factorial randomised controlled trial | Q30481543 | ||
| Teprotumumab for Thyroid-Associated Ophthalmopathy. | Q34556184 | ||
| Efficacy of B-cell targeted therapy with rituximab in patients with active moderate to severe Graves' orbitopathy: a randomized controlled study. | Q35055076 | ||
| Randomized controlled trial of rituximab in patients with Graves' orbitopathy | Q35055124 | ||
| The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' Orbitopathy | Q36811289 | ||
| Medical Treatment of Graves' Orbitopathy | Q38585021 | ||
| Advances in treatment of active, moderate-to-severe Graves' ophthalmopathy | Q38877933 | ||
| Long-term effects of Graves' ophthalmopathy on health-related quality of life | Q44011939 | ||
| Treatment of severe thyroid eye disease: a survey of the American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS). | Q45852178 | ||
| Randomized, single blind trial of intravenous versus oral steroid monotherapy in Graves' orbitopathy | Q46585048 | ||
| Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy. | Q50933902 | ||
| A randomized controlled trial of orbital radiotherapy versus sham irradiation in patients with mild Graves' ophthalmopathy. | Q53359335 | ||
| Efficacy and Safety of Three Different Cumulative Doses of Intravenous Methylprednisolone for Moderate to Severe and Active Graves' Orbitopathy | Q58109526 | ||
| Azathioprine in the treatment of thyroid-associated ophthalmopathy | Q68713064 | ||
| Prednisone and cyclosporine in the treatment of severe Graves' ophthalmopathy | Q69288448 | ||
| Orbital Cobalt Irradiation Combined with Systemic Corticosteroids for Graves' Ophthalmopathy: Comparison with Systemic Corticosteroids Alone* | Q70251349 | ||
| Ciclosporin and prednisone v. prednisone in treatment of Graves' ophthalmopathy: a controlled, randomized and prospective study | Q70321449 | ||
| Radiotherapy for Graves' orbitopathy: randomised placebo-controlled study | Q73761107 | ||
| Combined radiotherapy and medical immunosuppression in the management of thyroid eye disease | Q74216894 | ||
| A prospective, randomized, double-blind, placebo-controlled study of orbital radiotherapy for Graves' ophthalmopathy | Q74459180 | ||
| Orbital radiotherapy for Graves' ophthalmopathy | Q75236052 | ||
| Long-term outcome of a prospective randomized trial of conversion from cyclosporine to azathioprine treatment one year after renal transplantation | Q77590788 | ||
| P433 | issue | 4 | |
| P921 | main subject | multicenter clinical trial | Q6934595 |
| immunosuppression | Q1455316 | ||
| eye disease | Q3041498 | ||
| P304 | page(s) | 299-309 | |
| P577 | publication date | 2018-01-30 | |
| P1433 | published in | The Lancet: Diabetes & Endocrinology | Q27725107 |
| P1476 | title | Combined immunosuppression and radiotherapy in thyroid eye disease (CIRTED): a multicentre, 2 × 2 factorial, double-blind, randomised controlled trial. | |
| P478 | volume | 6 |
| Q89144001 | A British Ophthalmological Surveillance Unit (BOSU) study into dysthyroid optic neuropathy in the United Kingdom |
| Q91973798 | A survey of current practices by the British Oculoplastic Surgery Society (BOPSS) and recommendations for delivering a sustainable multidisciplinary approach to thyroid eye disease in the United Kingdom |
| Q60313273 | Corticosteroids for Graves’ Ophthalmopathy: Systematic Review and Meta-Analysis |
| Q49360050 | Graves' orbitopathy: the ongoing search for new treatment strategies. |
| Q90894014 | Interruption of autoimmunity for thyroid eye disease: B-cell and T-cell strategy |
| Q92335694 | New insights into the pathogenesis and nonsurgical management of Graves orbitopathy |
| Q64248548 | Orbital Radiotherapy Plus Concomitant Steroids in Moderate-to-Severe Graves' Ophthalmopathy: Good Results After Long-Term Follow-Up |
| Q102320345 | Teprotumumab for non-inflammatory thyroid eye disease (TED): evidence for increased IGF-1R expression |
Search more.